Kimia Biosciences Stock Price Analysis and Quick Research Report. Is Kimia Biosciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Kimia Biosciences. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Kimia Biosciences has a PE ratio of 18.1777909037212 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Kimia Biosciences has ROA of -5.0193% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Kimia Biosciences has a Current ratio of 0.8844.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Kimia Biosciences has a ROE of -183.2545%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Kimia Biosciences has a Debt to Equity ratio of 131.1218 which means that the company has high proportion of debt in its capital.

• Sales growth: Kimia Biosciences has reported revenue growth of -18.3942% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Kimia Biosciences for the current financial year is -0.460923085724641%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Kimia Biosciences is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Kimia Biosciences is Rs 2.0316. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Kimia Biosciences in Ticker for free. Also, one can get the intrinsic value of Kimia Biosciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Kimia Biosciences FAQs

Q1. What is Kimia Biosciences share price today?
Ans: The current share price of Kimia Biosciences is Rs 36.93.

Q2. What is the market capitalisation of Kimia Biosciences?
Ans: Kimia Biosciences has a market capitalisation of Rs 174.725952513 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Kimia Biosciences?
Ans: The PE ratio of Kimia Biosciences is 18.1777909037212 and the P/B ratio of Kimia Biosciences is 16.5709413981872, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Kimia Biosciences share?
Ans: The 52-week high share price of Kimia Biosciences is Rs 86.85, and the 52-week low share price of Kimia Biosciences is Rs 35.1.

Q5. Does Kimia Biosciences pay dividends?
Ans: Currently, Kimia Biosciences does not pay dividends. Dividend yield of Kimia Biosciences is around 0%.

Q6. What are the face value and book value of Kimia Biosciences shares?
Ans: The face value of Kimia Biosciences shares is Rs 1, while the book value per share of Kimia Biosciences is around Rs 2.2286. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Kimia Biosciences?
Ans: Kimia Biosciences has a total debt of Rs 43.4013 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Kimia Biosciences?
Ans: The ROE of Kimia Biosciences is -183.2545% and ROCE of Kimia Biosciences is -4.1794%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Kimia Biosciences a good buy for the long term?
Ans: The Kimia Biosciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Kimia Biosciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Kimia Biosciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Kimia Biosciences’s financials?
Ans: You can review Kimia Biosciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.